Sanofi Celebrates 50th Anniversary of Elysée Treaty
PR Newswire/Les Echos/
Sanofi Celebrates 50th Anniversary of Elysée Treaty - Supports First Two Academic Chairs for New Centre Virchow-Villermé for Public Health - Paris, France, October 21, 2013 - In commemoration of the 50th anniversary of the Elysée Treaty, Sanofi (EURONEXT:SAN and NYSE: SNY) today signed agreements to donate EUR2 million to support the first two academic chairs of the new French-German Centre Virchow-Villermé for Public Health. Sanofi Chief Executive Officer Christopher A. Viehbacher signed the agreements to support the two chairs during this year's World Health Summit held in Berlin. "In the 50th year of the Elysée Treaty, the donation of these first two Chairs further supports the intensive collaboration between our two countries in the field of science, politics and the economy," said Christopher A. Viehbacher during the signature ceremony. "It is only through partnership that we can succeed and through these chairs, we are bringing together actors in education, research, science and industry to make a real difference in promoting health and well-being." The Centre Virchow-Villermé for Public Health, founded in April 2013, is focused on interdisciplinary cooperation in the fields of education, research and expertise. One of the initial projects consists in a multilingual and open platform for internet-based learning (Massive Open Online Courses - MOOC), to offer remote courses in the field of Public Health. The project's primary aim is to enable students to benefit from high-quality courses in the field of Public Health in regions of Africa where infrastructure is lacking. The two academic chairs supported by Sanofi will be established in Berlin and in Paris, and will exclusively serve the purposes of the Centre Virchow-Villermé. The funds provided for a five-year period will be evenly shared between the two academic chairs. On behalf of the founding universities of both countries, the agreements were signed by Professor Annette Grüters-Kieslich, Dean of the Charité Medical University of Berlin, and Professor Frédéric Dardel, President of the Paris Descartes University (Sorbonne Paris Cité), as well as Martine Aiach, President of the Descartes Foundation. About the Centre Virchow-Villermé for Public Health The Centre Virchow-Villermé was set up in April 2013 as part of the commemoration of the 50th anniversary of the Elysée Treaty. The objective of the French-German Center jointly set up by the Charité Medical University of Berlin and Sorbonne Paris Cité is to focus on public health education, research and expertise with a deep commitment to interdisciplinary work. Sanofi is supporting the Virchow-Villermé project by funding the first two academic chairs of this unique French-German Center dedicated to Public Health. About Sanofi Sanofi, an integrated global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). Contacts: Relations Presse Relations Investisseurs Laurence Bollack Sébastien Martel Tel +33 (1) 53 77 46 46 Tel +33 (1) 53 77 45 45 firstname.lastname@example.org email@example.com
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.
-0- Oct/21/2013 10:09 GMT